Federal Policy
7Federal Policy·7:40 AM MT
The 2025 GOP budget law includes significant cuts to healthcare programs that are expected to result in higher premiums and changes to Medicaid eligibility rules. An estimated 2 million children could lose health insurance coverage as a result of these cuts. The changes are creating uncertainty around Medicaid coverage determinations and affordability challenges for families. The law represents a major shift in federal healthcare policy affecting both Medicaid and marketplace coverage.
Why it matters for managed careMedicaid managed care organizations will face enrollment declines, changes to member mix, and operational adjustments as eligibility rules tighten and children lose coverage under the new federal budget law.
Federal Policy·7:00 AM MT
The 2025 GOP budget law includes significant cuts to healthcare programs that may result in nearly 2 million children losing insurance coverage. The changes are causing higher health insurance premiums and creating confusion about Medicaid eligibility under new federal rules. While specific effective dates are not detailed in this report, the affordability challenges and coverage restrictions are already emerging. For Medicaid managed care organizations, these cuts will likely reduce pediatric enrollment, affecting capitation revenue and requiring operational adjustments to network capacity and eligibility systems.
Why it matters for managed careAnticipated enrollment declines from federal budget cuts will reduce MCO pediatric membership and capitation payments, requiring plans to adjust provider networks and administrative processes for new eligibility rules.
Federal Policy·7:40 PM MT
The CDC confirmed 2,030 measles cases in the U.S. as of June 4, 2026, with 1,890 cases (93%) linked to outbreaks. This total is rapidly approaching the full-year 2025 count. Measles is a highly contagious vaccine-preventable disease that poses particular risks to immunocompromised populations and young children. For Medicaid managed care plans, rising case counts may trigger increased EPSDT screening requirements, higher utilization of pediatric acute care and emergency services, and potential quality measure impacts related to childhood immunization rates.
Why it matters for managed careMedicaid MCOs serving pediatric and immunocompromised populations may see increased acute care utilization and face pressure to improve immunization rates under HEDIS and quality bonus programs.
Federal Policy·7:40 PM MT
The Trump administration has reclassified thousands of HHS employees who shape policy to Schedule F status, stripping civil service protections and making them easier to terminate. The change affects staff across HHS agencies including CMS who develop regulations, guidance, and policy implementation. This action mirrors a similar executive order from Trump's first term that was rescinded by the Biden administration. The reclassification takes effect immediately and could lead to significant turnover among career staff who oversee Medicaid policy development and managed care oversight.
Why it matters for managed carePotential turnover among CMS career staff who write managed care rules, issue guidance, and oversee MCO compliance could create regulatory uncertainty and disrupt existing agency relationships that health plans rely on for policy interpretation.
Federal Policy·7:40 PM MT
The Food and Drug Administration has initiated a safety review of mifepristone, the abortion medication, according to an administration official. The retrospective analysis could lead to restrictions on the drug's use and distribution channels. Anti-abortion groups view this as a significant development that may result in tighter federal controls over medication abortion access. The timing and scope of the review have not been disclosed.
Why it matters for managed careIf FDA restricts mifepristone distribution or availability, Medicaid managed care plans may face changes to pharmacy networks, prior authorization protocols, and access to medication abortion services covered under state Medicaid programs.
Federal Policy·7:00 PM MT
The Food and Drug Administration has initiated a safety review of mifepristone, the abortion medication used in medication abortions. The retrospective data analysis follows pressure from anti-abortion groups and could lead to new restrictions on the drug's use and distribution. The review's timing and scope remain unclear, but any resulting restrictions would affect Medicaid managed care organizations that cover reproductive health services. Medicaid is the largest payer for births in the United States and covers family planning services for millions of beneficiaries.
Why it matters for managed careRestrictions on mifepristone access could affect MCO formularies, prior authorization protocols, pharmacy networks, and member access to covered reproductive health services in states where abortion remains legal.
Federal Policy·7:00 PM MT
The Trump administration has reclassified thousands of HHS employees who develop and implement policy into a new employment category that removes civil service protections and makes them easier to terminate. The change affects staff across HHS agencies who work on regulatory development, program policy, and implementation guidance. This reclassification is effective immediately under executive authority. The move creates significant uncertainty for Medicaid program staff at CMS and other HHS divisions who draft regulations, issue guidance, and oversee state programs and managed care operations.
Why it matters for managed carePolicy continuity and institutional knowledge at CMS could be disrupted if experienced staff who write Medicaid rules, review state plan amendments, and oversee managed care compliance are terminated or leave due to employment uncertainty.
Managed Care
5Managed Care·7:40 PM MT
The CMS rule requiring 72-hour prior authorization decisions for urgent requests is creating operational friction by accelerating approvals without corresponding improvements in billing and payment cycles. Health plans and providers now face misaligned timelines where clinical decisions move faster than claims processing and reimbursement. The policy change, which took effect for most payers in 2024, highlights gaps in interoperability and revenue cycle infrastructure. Managed care organizations are experiencing the downstream effects as prior authorization reform outpaces backend payment modernization.
Why it matters for managed careMCOs must address operational misalignment between accelerated prior authorization timelines mandated by CMS and legacy billing systems to avoid cash flow disruption and provider network friction.
Managed Care·7:00 PM MT
New requirements for expedited prior authorization decisions — particularly the 72-hour standard for urgent requests under CMS interoperability rules — are creating operational friction as payers accelerate approval timelines while back-end billing and payment processes remain unchanged. Health plans and providers are experiencing cash flow mismatches as authorization speed outpaces claims adjudication and reimbursement cycles. The disconnect highlights the need for corresponding modernization in payment infrastructure to match prior authorization reforms. This affects Medicaid managed care organizations subject to federal prior authorization timeframe requirements under the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F).
Why it matters for managed careMedicaid MCOs must accelerate authorization decisions under federal timelines while managing provider relations strained by unchanged payment cycles, creating operational pressure and potential network adequacy risks.
Managed Care·7:00 PM MT
The CDC reports 2,030 confirmed measles cases in the U.S. as of June 4, 2026, with 1,890 cases (93%) linked to outbreaks. This figure is rapidly approaching last year's full annual total. The surge in measles transmission reflects declining vaccination rates and increased outbreak activity across multiple jurisdictions. Medicaid managed care plans covering children are responsible for ensuring EPSDT compliance, including MMR vaccination coverage and outbreak response coordination with state and local health departments.
Why it matters for managed careMedicaid MCOs face heightened regulatory scrutiny on pediatric immunization rates under EPSDT and HEDIS measures, plus potential encounter surge costs from outbreak-related emergency department visits and hospitalizations in covered populations.
Managed Care·7:40 AM MT
Beginning in January, physician billing codes for pregnancy care will transition from a bundled reimbursement model to fee-for-service billing for individual visits and services. Obstetricians say the new codes will more accurately capture variation in care delivery. However, the shift from global maternity packages to unbundled billing creates risk for overutilization and increased costs. Medicaid managed care organizations should review their maternity care contracts and utilization management protocols to address potential volume increases under the new coding structure.
Why it matters for managed careThe transition to unbundled OB billing could increase pregnancy care costs for MCOs through higher visit volumes and duplicative services unless utilization management and contract terms are adjusted.
Managed Care·7:00 AM MT
Starting in January, physician billing codes for pregnancy care will change from a bundled payment structure to individual fee-for-service codes. Obstetricians say the new à la carte approach will better reflect the actual care delivered, but the shift may create incentives for providers to increase the number of visits and services. The change affects how managed care organizations pay for and manage maternity care, a significant cost driver in Medicaid programs that cover approximately 42% of all U.S. births. MCOs will need to update payment methodologies, utilization management protocols, and monitor for potential overutilization.
Why it matters for managed careThe shift from bundled to unbundled maternity billing could increase costs and utilization, requiring MCOs to update payment models, strengthen utilization review, and adjust actuarial assumptions for a benefit category that accounts for a substantial portion of Medicaid spending.